The Global Mantle Cell Lymphoma Market offers significant growth potential driven by an aging population increasing cancer ...
A 13-year-old terrier-lab mix serving as a veteran's service dog receives cancer treatment through LSU's veterinary oncology ...
Patients with Waldenström Non-Hodgkin lymphoma in the U.S. achieved durable complete responses of up to 15 months using a chemotherapy-free CD19 CAR-NK (chimeric antigen receptor natural killer) cell ...
Cancer survivors' follow-up frequency depends on cancer type, treatment response, and individual factors, including insurance coverage. Recent CT results showed slightly increased mesenteric nodes, ...
The Food and Drug Administration (FDA) has approved Breyanzi ® (lisocabtagene maraleucel; liso-cel) for the treatment of adult patients with relapsed or refractory (R/R) marginal zone lymphoma (MZL) ...
Opportunities in the Global Refractory Follicular Lymphoma Diagnostics Market include the growing need for MRD monitoring and ...
People affected by lymphoma are set to benefit from a free workshop. Held virtually, the 'Live your Life' event will take ...
A 25-year-old woman who said a GP “laughed” at her when she suggested she might have cancer later discovered she had Hodgkin ...
In mantle cell lymphoma (MCL), an aggressive form of B-cell non-Hodgkin lymphoma, TP53 mutations are known to affect patients’ prognosis—but questions remain. What does the heterogeneity of TP53 ...
Michael Wang, MD, highlights ASH 2025 data showing how continual innovation across targeted agents, cellular and immune ...
3hon MSN
Former Japanese PM Shinzo Abe's killer motivated by 'disgust' at links to Unification Church
The man who killed former Japanese prime minister Shinzo Abe thought it was his life's mission to destroy a controversial ...
Corvus Pharmaceuticals, Inc. jumps 165% on Phase 1 soquelitinib atopic dermatitis data; learn key efficacy, funding, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results